Accessibility Menu
 

Alumis

(NASDAQ) ALMS

Current Price$23.40
Market Cap$2.97B
Since IPO (2024)+76%
5 YearN/A
1 Year+138%
1 Month-17%

Alumis Financials at a Glance

Market Cap

$2.97B

Revenue (TTM)

$24.05M

Net Income (TTM)

$243.32M

EPS (TTM)

$-3.00

P/E Ratio

-7.79

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$23.40

Volume

45,765

Open

$22.25

Previous Close

$23.40

Daily Range

$21.93 - $23.88

52-Week Range

$2.76 - $30.60

ALMS: Motley Fool Moneyball Superscore

61

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alumis

Industry

Pharmaceuticals

Employees

224

CEO

Martin Babler

Headquarters

South San Francisco, CA 94080, US

ALMS Financials

Key Financial Metrics (TTM)

Gross Margin

96%

Operating Margin

-18%

Net Income Margin

-10%

Return on Equity

-87%

Return on Capital

-1%

Return on Assets

-59%

Earnings Yield

-12.84%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.97B

Shares Outstanding

127.20M

Volume

45.77K

Short Interest

0.00%

Avg. Volume

3.11M

Financials (TTM)

Gross Profit

$20.55M

Operating Income

$427.20M

EBITDA

$423.71M

Operating Cash Flow

$369.52M

Capital Expenditure

$653.00K

Free Cash Flow

$370.18M

Cash & ST Invst.

$308.50M

Total Debt

$36.91M

Alumis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.93M

N/A

Gross Profit

$1.06M

+229.5%

Gross Margin

55.05%

N/A

Market Cap

$2.97B

N/A

Market Cap/Employee

$17.69M

N/A

Employees

168

N/A

Net Income

$92.93M

+1.9%

EBITDA

$83.68M

+10.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$271.59M

+5.5%

Accounts Receivable

$2.08M

+15.0%

Inventory

$0.00

N/A

Long Term Debt

$32.24M

+10.6%

Short Term Debt

$4.67M

+199.9%

Return on Assets

-59.07%

N/A

Return on Invested Capital

-1.31%

N/A

Free Cash Flow

$71.91M

+4.3%

Operating Cash Flow

$71.91M

+3.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RAPTRAPT Therapeutics, Inc.
$58.01+0.00%
OMEROmeros Corporation
$10.90-9.77%
ETONEton Pharmaceuticals, Inc.
$24.99-1.46%
LXRXLexicon Pharmaceuticals, Inc.
$1.59-3.05%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NOKNokia
$8.82+0.07%

Questions About ALMS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.